What biomarker testing is recommended for locally advanced Breast Cancer
Biomarker Testing for Locally Advanced Breast Cancer
Based on current clinical guidelines, here's what biomarker testing is typically recommended for locally advanced breast cancer:
Standard Biomarker Testing
According to NCCN Guidelines for Invasive Breast Cancer, your care team will recommend biomarker testing on a sample from your tumor biopsy. The standard tests include:
Hormone Receptor Status (Essential)
- Estrogen Receptor (ER) and Progesterone Receptor (PR) testing
- These determine if your cancer cells use hormones to grow
- Results guide whether hormone-blocking therapies will be effective
HER2 Status (Essential)
- Tests for HER2 protein overexpression or gene amplification
- HER2-positive cancers respond to targeted HER2 therapies
- This is a critical decision point for treatment planning
Additional Tumor Mutation Testing
The NCCN Guidelines recommend testing for specific DNA mutations that can be targeted with therapies, including:
- PIK3CA mutations – can be treated with targeted therapies like alpelisib
- AKT1 mutations – targetable with specific inhibitors
- PTEN alterations – may guide treatment selection
- ESR1 mutations – typically tested in hormone receptor-positive tumors
- NTRK and RET fusions – rare but actionable if present
Testing Methods
According to NCCN Guidelines, these tests use various laboratory methods:
- Next-generation sequencing (NGS) – comprehensive DNA analysis
- Immunohistochemistry (IHC) – protein detection
- FISH (Fluorescence In Situ Hybridization) – gene amplification detection
- PCR (Polymerase Chain Reaction) – sensitive mutation detection
Germline (Inherited) Testing
The NCCN Guidelines recommend germline BRCA1/2 testing for patients with breast cancer, as this information affects:
- Your personal cancer risk
- Family members' risk
- Treatment options (PARP inhibitors if mutations present)
- Genetic counseling needs
Tumor Markers (Blood Tests)
Your doctor may also check blood-based tumor markers like:
- CA 15-3 and CA 27.29
- These can help monitor treatment response over time
- However, they're not reliable for initial diagnosis
Questions to Ask Your Oncology Team
- Which biomarker tests have been done on my tumor, and what were the results?
- Are there any actionable mutations that would change my treatment approach?
- Do I need germline BRCA testing, and if so, when should that be done?
- Will you be doing liquid biopsy (blood-based testing) in addition to tissue testing?
- How will these biomarker results affect my treatment plan?
Why This Matters
Biomarker testing transforms breast cancer from a "one-size-fits-all" disease into a personalized medicine approach. Your specific biomarker profile determines which treatments are most likely to work for YOUR cancer, potentially improving outcomes while minimizing unnecessary side effects.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Invasive Breast Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 15, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Breast Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Breast Cancer
- What clinical trials are available for locally advanced Breast Cancer
- What does biomarker testing for ER, PR, and HER2 mean in breast cancer
- What is the standard of care for locally advanced Breast Cancer according to NCCN guidelines
- Is surgery recommended for Breast Cancer and when
- What steps do I need to take to prepare for the biomarker testing process? Is there anything I should avoid before...
- Should I get BRCA testing for breast cancer
- What are the key biomarkers in breast cancer
- Should my family get genetic testing if I have Breast Cancer